research

"There's not one fix" to ensuring patient access to innovative medicine. That appeared to be the consensus of moderator Christi Shaw, president, Novartis Pharmaceuticals Corporation and panelists, discussing the opportunities and challenges in getting new therapies to patients with complex and chronic conditions like cancer, multiple sclerosis and rheumatoid arthritis during a super session today at the BIO International Convention. Is the cost of some drugs a barrier? Are we adequately pricing the value of innovation? To ensure breakthroughs continue to reach patients, Scott Gottlieb, resident fellow, American Enterprise Institute, suggested that we need an approach to financing care that'...
Research organizations are about as diverse as the scientists, clinicians and engineers they support. With that diversity comes differing strengths: at academic health centers, physicians and scientists work side-by-side to bring new laboratory discoveries to the care of patients, to educate and train future health professionals and to serve their local communities. Government laboratory investigators, on the other hand, assemble teams from multiple disciplines to work towards a handful of goals, build large and one-of-a-kind scientific instruments, and connect through a national network in the federal system. Here in the Pacific Northwest, our two research organizations – a public health...
As many as one-half of all cancers are preventable based on what we already understand. Despite many promising and innovative new therapies, cancer prevention remains “Plan A,” our first and best hope to reduce the burden of this disease. I recently shared key points of this plan, described below, in a June 1, 2015 lecture at the American Society of Clinical Oncology Annual Meeting. At The University of Texas MD Anderson Cancer Center , we established the cancer prevention and control platform within the Moon Shots program. Our mission is to develop and implement evidence-based actions in cancer prevention, screening, early detection and survivorship in clinical and community settings to...
Dear Research Advocate: That so many well-informed patient advocates are working for House passage of the 21st Century Cures bill (H.R. 6) is an excellent indication of just how important this legislation is to all of us looking for answers to what (literally) ails us. This makes it all the more puzzling that there aren’t more supporters weighing in from the science community. It may be because many don’t know about the bill yet -- a preliminary report from a poll of scientists we have in the field right now shows that only one in 5 members of the science community say they have heard of the bill. If you are a researcher and a regular reader of this letter, I know you know about it! Will...
Hardly anyone knew that 28-year-old Monique Gore-Massy was sick on her wedding day in 2008, but just two months earlier, she had been diagnosed with lupus. Before then, Monique had been coping with symptoms such as fever, chronic body pain, swelling of her joints, hair loss, shortness of breath and mouth sores without understanding why. First she was prescribed antibiotics and then told she was suffering from a viral infection. After nearly a year of confusion and misdiagnosis, Monique was finally diagnosed with lupus. Unfortunately, Monique’s experience is all too common. A recent study found that a majority of people with lupus surveyed (63 percent) reported being incorrectly diagnosed...
Today is a social media Day of Action for Research!America and our #FindFundCure campaign. Join us all day on Twitter and Facebook by using the hashtag #findfundcure and make your voice heard. While Congress debates its budget for the upcoming fiscal year, we will advocate for accelerated progress in biomedical innovation by pressing for more research funding. Join us and share personal stories, relevant data, and compelling visuals to make the case that insufficient funding costs lives. It’s time to find the money, fund the research, and cure the disease! Spread the word and share our Day of Action toolkit , complete with sample messages and resource links, with your professional and...
Calls for greater federal investments in science and innovation are gaining momentum among Members of Congress and influencers. The nation’s leaders from across the political spectrum continue to push for more federal investments in research at this critical time as the government spends less on science as a percentage of GDP than it did 40 years ago. Research!America has collected recent quotes from opinion leaders and decision-makers. The quotes speak to their support for increasing science and research funding, and emphasize the importance of speaking out on this issue. To view the quotes, click here .
Dear Research Advocate: Research!America yesterday released our recommendations for the top five science priorities the new Congress should address in its first 100 days: end sequestration, increase funding for our nation’€™s research agencies, advance the 21st Century Cures Initiative legislation, repeal the medical device tax, and enact a permanent and enhanced R&D tax credit. See the full press release here . Among these priorities, ending sequestration is the steepest uphill climb – but what a difference it would make for the future of health and the nation’s economy! That’€™s the focus of this editable message to members of Congress. Please weigh in! Securing meaningful increases...
Dear Research Advocate: The 2014 Nobel Laureates will be announced next week. I hope you will consider amplifying the news via social media, op-eds and letters to the editor. The Nobel prize is so iconic that it provides an entrée to the broader public, one that can be used to connect the dots between the process of scientific discovery, the power of ingenuity, and the role of science in human progress. And if a winner has been funded by a U.S. science agency or company, all the better from an advocacy perspective! In the years ahead, will the United States be home to more Nobel Laureates in the sciences, or will those honors go to scientists in countries that place a greater emphasis on...
By Israel Rocha, CEO, Doctors Hospital at Renaissance September 15 marks the beginning of Hispanic Heritage Month, a time to pay tribute to the generations of Hispanics who have enriched America’€™s history. It’€™s also an important time to consider how this community can be further empowered to make important contributions, particularly in the future of health care. Research demonstrates that certain diseases disproportionately impact the Hispanic community, including diabetes, liver cancer, cervical cancer and HIV/AIDS. Clinical trials help researchers find better ways to diagnose, prevent and treat these diseases and others. However, Hispanics are significantly underrepresented in...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln